1. /
  2. Our work /
  3. Projects /
  4. Discovering novel antimalarials to block parasite invasion of human cells
INVASION

Discovering novel antimalarials to block parasite invasion of human cells

Drugs are the main weapons used to combat malaria infection, but parasites are becoming resistant and new medicines and drug targets are needed. We are developing new antimalarials that prevent the parasite from entering the host red blood cell. If the parasite cannot invade, it cannot cause disease. We use our extensive history in deciphering the invasion process of malaria parasites to inform drug discovery.

Objective 

We seek to better understand how the malaria parasite enters red blood cells, and to use this knowledge to discover and develop novel therapeutics.

Timeline

2003–ongoing.

Approach

We are pioneers in using live cell microscopy to investigate how malaria parasites get into host red blood cells. We use this specialised technique to aid in our discovery of novel antimalarial compounds that inhibit this process.

Community impact

Better, safer and cheaper antimalarial drugs would benefit endemic communities around the world and could accelerate malaria elimination. The research will also provide new knowledge about parasite biology that could inform future treatment options.

Research and reports

10 Oct 2023

Bottoms up! Malaria parasite invasion the right way around.

Andrews M, Baum J, Gilson PR, Wilson DW

15 Nov 2022

Characterisation of PfCZIF1 and PfCZIF2 in Plasmodium falciparum asexual stages.

International journal for parasitology

Balbin JM, Heinemann GK, Yeoh LM, Gilberger TW, Armstrong M, Duffy MF, Gilson PR, Wilson DW

15 Sep 2023

The dual action of human antibodies specific to Plasmodium falciparum PfRH5 and PfCyRPA: Blocking invasion and inactivating extracellular merozoites.

PLoS pathogens

Weiss GE, Ragotte RJ, Quinkert D, Lias AM, Dans MG, Boulet C, Looker O, Ventura OD, Williams BG, Crabb BS

27 Feb 2023

Defining species-specific and conserved interactions of apical membrane protein 1 during erythrocyte invasion in malaria to inform multi-species vaccines.

Cellular and molecular life sciences : CMLS

Drew DR, Wilson DW, Weiss GE, Yeoh LM, G Henshall I, Crabb BS, Dutta S, Gilson PR, Beeson JG

18 Aug 2023

Plasmodium falciparum formins are essential for invasion and sexual stage development.

Communications biology

Collier S, Pietsch E, Dans M, Ling D, Tavella TA, Lopaticki S, Marapana DS, Shibu MA, Andrew D, Tiash S

16 Feb 2022

Structure of the Pf12 and Pf41 heterodimeric complex of Plasmodium falciparum 6-cysteine proteins.

FEMS microbes

Dietrich MH, Chan LJ, Adair A, Boulet C, O'Neill MT, Tan LL, Keremane S, Mok YF, Lo AW, Gilson P

03 Mar 2020

Screening the Medicines for Malaria Venture Pathogen Box for invasion and egress inhibitors of the blood stage of Plasmodium falciparum reveals several inhibitory compounds.

International journal for parasitology

Dans MG, Weiss GE, Wilson DW, Sleebs BE, Crabb BS, de Koning-Ward TF, Gilson PR

31 Jul 2019

Targeting malaria parasite invasion of red blood cells as an antimalarial strategy.

FEMS microbiology reviews

Burns AL, Dans MG, Balbin JM, de Koning-Ward TF, Gilson PR, Beeson JG, Boyle MJ, Wilson DW

10 Sep 2019

Malaria vaccine candidates displayed on novel virus-like particles are immunogenic and induce transmission-blocking activity.

PloS one

Chan JA, Wetzel D, Reiling L, Miura K, Drew DR, Gilson PR, Anderson DA, Richards JS, Long CA, Suckow M

13 Jun 2019

Human Antibodies that Slow Erythrocyte Invasion Potentiate Malaria-Neutralizing Antibodies.

Cell

Alanine DGW, Quinkert D, Kumarasingha R, Mehmood S, Donnellan FR, Minkah NK, Dadonaite B, Diouf A, Galaway F, Silk SE

08 Oct 2019

Protein Kinase A Is Essential for Invasion of Plasmodium falciparum into Human Erythrocytes

Wilde ML, Triglia T, Marapana D, Thompson JK, Kouzmitchev AA, Bullen HE, Gilson PR, Cowman AF, Tonkin CJ

12 Apr 2019

Functional Conservation of the AMA1 Host-Cell Invasion Ligand Between P. falciparum and P. vivax: A Novel Platform to Accelerate Vaccine and Drug Development.

The Journal of infectious diseases

Drew DR, Sanders PR, Weiss G, Gilson PR, Crabb BS, Beeson JG

11 Nov 2016

Differing rates of antibody acquisition to merozoite antigens in malaria: implications for immunity and surveillance.

Journal of leukocyte biology

McCallum FJ, Persson KE, Fowkes FJ, Reiling L, Mugyenyi CK, Richards JS, Simpson JA, Williams TN, Gilson PR, Hodder AN

Partners

Funding partners

  • National Health and Medical Research Council (NHMRC)

Collaborators

  • WEHI (Brad Sleebs, William Nguyen, Madeline Dans)
  • Deakin University/Burnet Institute (Alyssa Barry)
  • Deakin University (Tania de Koning-Ward)
  • Monash University (Darren Creek, Ghizal Siddiqui)

Project contacts

Associate Professor Paul Gilson

Associate Professor Paul Gilson

Deputy Discipline Head, Life Sciences; Co-Head, Malaria Virulence and Drug Discovery Group; Head of Burnet Cell Imaging Facility
View profile

Project team

Associate Professor Paul Gilson

Associate Professor Paul Gilson

Deputy Discipline Head, Life Sciences; Co-Head, Malaria Virulence and Drug Discovery Group; Head of Burnet Cell Imaging Facility
View profile
Claudia Barnes

Claudia Barnes

Research Assistant
View profile
Dr Hayley Bullen

Dr Hayley Bullen

Co-Head, Malaria Virulence and Drug Discovery Group
View profile
Professor Brendan Crabb AC

Professor Brendan Crabb AC

Director and CEO; Chair Australian Global Health Alliance and Chair Pacific Friends of Global Health
View profile
Alysha Literski

Alysha Literski

PhD student
View profile
Dr Oliver Looker

Dr Oliver Looker

Postdoctoral Scientist
View profile
Molly Schneider

Molly Schneider

Research Assistant
View profile
On this page